文献速递疼痛医学

胸交感神经节阻滞:207例慢性疼痛患者的真实世界结局

Thoracic sympathetic ganglion blocks: real-world outcomes in 207 chronic pain patients.
PubMed 文献 · Reg Anesth Pain Med · 2024-07-08

本研究回顾性分析2004至2020年接受胸交感神经节阻滞(TSGB)的232例患者,最终分析207例。结果显示,术后温度升高与疼痛缓解无显著相关(R=0.013,p=0.855);合并糖尿病(OR 4.200)和辅助用药(OR 3.451)与阳性结局正相关,精神共病(OR 0.327)和疼痛病程(OR 0.973)负相关。

要点

  • TSGB技术成功与疼痛缓解无显著相关,温度升高不能预测镇痛效果。
  • 糖尿病和辅助用药与阳性结局正相关,精神共病和长病程负相关。
  • 需进一步研究复杂区域疼痛综合征和神经病理性疼痛的预测因素。

核心结论

  • TSGB后温度升高与疼痛缓解无显著关联。

研究设计与样本

  • 回顾性研究,纳入2004至2020年接受TSGB的232例患者,最终分析207例。

主要发现

  • 115例(55.5%)患者对TSGB呈阳性反应,139例(67.1%)技术成功。
  • 疼痛缓解与温度升高无显著关系(R=0.013,p=0.855)。
  • 糖尿病(OR 4.200)和辅助用药(OR 3.451)与阳性结局正相关。
  • 精神共病(OR 0.327)和疼痛病程(OR 0.973)与阳性结局负相关。

关键数值与推荐

  • 技术成功定义为20分钟时温度升高≥1.5°C。
  • 阳性结局定义为TSGB后2周11点数字评定量表疼痛下降≥2分。

临床怎么用

  • TSGB疗效评估不应仅依赖温度升高,需结合疼痛评分变化。
  • 对合并糖尿病、辅助用药、精神共病及长病程患者应个体化评估预期。

局限性

  • 回顾性设计,结论需前瞻性研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thoracic sympathetic ganglion block (TSGB) is a procedure to manage sympathetically maintained upper extremity pain (sympathetically maintained pain). To date, only a few studies have evaluated the clinical effectiveness of TSGB in pain medicine. This study investigated (1) the relationship between technical success of TSGB and pain reduction in patients with chronic upper extremity pain and (2) relevant clinical factors for a positive TSGB outcome. METHODS: We retrospectively reviewed medical data in 232 patients who received TSGB from 2004 to 2020. Technical success and a positive outcome of TSGB were defined as a temperature increase of ≥1.5°C at 20 min and a pain reduction with ≥2 points on the 11-point Numerical Rating Scale at 2 weeks post-TSGB, respectively. Correlations were assessed using correlation coefficients (R), and multivariable regression model was used to identify factors relevant to TSGB outcomes. RESULTS: 207 patients were ultimately analyzed; among them, 115 (55.5%) patients positively responded to TSGB, and 139 (67.1%) achieved technical success after TSGB. No significant relationship existed between the pain reduction and the temperature increase after TSGB (R=0.013, p=0.855). Comorbid diabetes (OR 4.200) and adjuvant intake (OR 3.451) were positively associated, and psychiatric comorbidity (OR 0.327) and pain duration (OR 0.973) were negatively associated with TSGB outcome. CONCLUSIONS: We found no significant association between the temperature increase and pain reduction after TSGB. Further studies are warranted to identify significant factors associated with TSGB outcomes in patients with complex regional pain syndrome and neuropathic pain diseases.

来源:Reg Anesth Pain Med,查看原文。版权归原作者所有。

引用

  1. Kim J, Yun M, Han AH, et al. Thoracic sympathetic ganglion blocks: real-world outcomes in 207 chronic pain patients. Reg Anesth Pain Med. 2024. PMID: 37726196. doi:10.1136/rapm-2023-104624

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。